Correlation Between In8bio and Anebulo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both In8bio and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining In8bio and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between In8bio Inc and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on In8bio and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in In8bio with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of In8bio and Anebulo Pharmaceuticals.
Diversification Opportunities for In8bio and Anebulo Pharmaceuticals
0.2 | Correlation Coefficient |
Modest diversification
The 3 months correlation between In8bio and Anebulo is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding In8bio Inc and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and In8bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on In8bio Inc are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of In8bio i.e., In8bio and Anebulo Pharmaceuticals go up and down completely randomly.
Pair Corralation between In8bio and Anebulo Pharmaceuticals
Given the investment horizon of 90 days In8bio Inc is expected to under-perform the Anebulo Pharmaceuticals. In addition to that, In8bio is 1.89 times more volatile than Anebulo Pharmaceuticals. It trades about -0.04 of its total potential returns per unit of risk. Anebulo Pharmaceuticals is currently generating about -0.07 per unit of volatility. If you would invest 165.00 in Anebulo Pharmaceuticals on November 4, 2024 and sell it today you would lose (11.00) from holding Anebulo Pharmaceuticals or give up 6.67% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
In8bio Inc vs. Anebulo Pharmaceuticals
Performance |
Timeline |
In8bio Inc |
Anebulo Pharmaceuticals |
In8bio and Anebulo Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with In8bio and Anebulo Pharmaceuticals
The main advantage of trading using opposite In8bio and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if In8bio position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.In8bio vs. Reviva Pharmaceuticals Holdings | In8bio vs. Cue Biopharma | In8bio vs. Lantern Pharma | In8bio vs. Anixa Biosciences |
Anebulo Pharmaceuticals vs. Adagene | Anebulo Pharmaceuticals vs. Acrivon Therapeutics, Common | Anebulo Pharmaceuticals vs. AnaptysBio | Anebulo Pharmaceuticals vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |